Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of RO7890597 in Healthy Volunteers
NCT07797478Phase 1Recruiting
- Sponsor
- Genentech
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, randomised trial comparing RO7890597 with Placebo (2 arms). Primary endpoint: Incidence and Severity of Adverse Events at 12 weeks. Started Aug 2026; status: recruiting.
02
Drugs
RO7890597
Beyond the preview
Go deeper on NCT07797478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07797478.